<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04989153</url>
  </required_header>
  <id_info>
    <org_study_id>ç ”2015-079</org_study_id>
    <nct_id>NCT04989153</nct_id>
  </id_info>
  <brief_title>Nasal Endoscopic Screening and Risk Assessment for Early Gastric Cancer</brief_title>
  <official_title>China Health Promotion Foundation/the Second Affiliated Hospital of Zhejiang University, School of Medicine</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Second Affiliated Hospital, School of Medicine, Zhejiang University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Jilin City People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>No. 924 Hospital of the People's Liberation Army of China</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Kunshan Hospital of Traditional Chinese Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Chinese PLA General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sichuan Provincial People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Affiliated Hospital of Southwest Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Zhongshan Hospital Xiamen University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Jingzhou Hospital of Traditional Chinese Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Changhai Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Second Affiliated Hospital, School of Medicine, Zhejiang University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pepsinogens (PGs) can be used for gastric cancer (GC) screening, but the cutoff levels vary&#xD;
      among studies, and PG levels are influenced by numerous factors. To examine the diagnostic&#xD;
      value of PG levels and Helicobacter pylori (Hp) status for GC and precancerous lesions&#xD;
      screening in asymptomatic individuals undergoing health checkup in China.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Pepsinogens (PGs) can be used for gastric cancer (GC) screening, but the cutoff levels vary&#xD;
      among studies, and PG levels are influenced by numerous factors. To examine the diagnostic&#xD;
      value of PG levels and Helicobacter pylori (Hp) status for GC and precancerous lesions&#xD;
      screening in asymptomatic individuals undergoing health checkup in China. We operated a&#xD;
      multicenter cross-sectional study of subjects who underwent health checkup at nine&#xD;
      International Healthcare Centers in China. All participants underwent gastroscopy and&#xD;
      pathological examination, serum PG, 13C-urea breath test, and/or Hp serological current&#xD;
      infection marker rapid test, all on the same day. PG related parameters were analyzed in&#xD;
      different Hp subgroups and regions.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 5, 2016</start_date>
  <completion_date type="Anticipated">December 6, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>6 Years</target_duration>
  <primary_outcome>
    <measure>serum pepsinogen levels for GC and precancerous lesions</measure>
    <time_frame>1 year</time_frame>
    <description>cutoff values of pepsinogen level for GC and precancerous lesions in different regions in China and in different HP status</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Risk factors for GC</measure>
    <time_frame>1 year</time_frame>
    <description>the risk factors for GC, according to the logistic regression model</description>
  </primary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">5000</enrollment>
  <condition>Gastric Cancer</condition>
  <condition>Precancerous Lesion</condition>
  <condition>Helicobacter Pylori Infection</condition>
  <arm_group>
    <arm_group_label>non-atrophic gastritis</arm_group_label>
    <description>No atrophic gastritis, The OLGA-0 group;OLGA :Operative Link on Gastritis Assessment)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>mild-moderate atrophic gastritis</arm_group_label>
    <description>The OLGA I-II group;OLGA :Operative Link on Gastritis Assessment)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>severe atrophic gastritis</arm_group_label>
    <description>The OLGA III-IV group;OLGA :Operative Link on Gastritis Assessment)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>gastric cancer</arm_group_label>
    <description>gastric cancer</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>pepsinogen</intervention_name>
    <description>serum pepsinogen diagnosed gastric cancer and precanceous lesion</description>
    <arm_group_label>gastric cancer</arm_group_label>
    <arm_group_label>severe atrophic gastritis</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        consecutive subjects who underwent regular health checkup at nine International Healthcare&#xD;
        Centers in different regions of China&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        intention to undergo gastroscopy during health checkup examination 25-75 years of age.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        a history of gastric ulcer, gastric polyp, or GC a history of gastrectomy treatment with a&#xD;
        proton pump inhibitor in the last month contraindications to gastroscopy a history of Hp&#xD;
        eradication a history of abdominal pain, abdominal distention, belching, acid reflux,&#xD;
        nausea and other digestive tract symptoms within 1 month incomplete data.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yi Zhao, Master</last_name>
    <role>Principal Investigator</role>
    <affiliation>2nd affiliated hospital of Zhejiang university, school of medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Zhenya Song, Dr.</last_name>
    <phone>13600529612</phone>
    <email>songzhenya@zju.edu.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yuling Tong, Dr.</last_name>
    <phone>13758281220</phone>
    <email>tongyl0313@zju.edu.cn</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Jilin City People's Hospital</name>
      <address>
        <city>Jilin</city>
        <state>Jilin</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hongguang Wang</last_name>
      <email>406346148@qq.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Chinese PLA General Hospital</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hong Li</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sichuan Provincial People's Hospital</name>
      <address>
        <city>Chengdu</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lirong Gong</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The First Hospital affiliated to AMU (Southwest Hospital)</name>
      <address>
        <city>Chongqing</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hongbo Wu</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>No. 924 Hospital of the People's Liberation Army of China</name>
      <address>
        <city>Guilin</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xueqiang He</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Jingzhou Hospital of Traditional Chinese Medicine</name>
      <address>
        <city>Jingzhou</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yinhu Luo</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kunshan Hospital of Traditional Chinese Medicine</name>
      <address>
        <city>Kunshan</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hongwei Xu</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Shanghai Changhai Hospital</name>
      <address>
        <city>Shanghai</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dong Wang</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Zhongshan Hospital affiliated to Xiamen University</name>
      <address>
        <city>Xiamen</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hongzhi Xu</last_name>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 8, 2021</study_first_submitted>
  <study_first_submitted_qc>July 25, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 4, 2021</study_first_posted>
  <last_update_submitted>July 25, 2021</last_update_submitted>
  <last_update_submitted_qc>July 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stomach Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

